|transkript [Kääb, Georg]. (11/4/22). "News: Ayoxxa insolvent – vom Investor sitzen gelassen".

	Region	Köln (Cologne)
	Country	Germany
	Organisation	Ayoxxa Biosystems GmbH
	Group	Ayoxxa (Group)
	Organisation 2	Prosnav Capital, Luxembourg Fund Office
	Group	Prosnav Capital (Group)
	Product	Lunaris™ multiplex protein quantification platform
	Product 2	venture capital
	Index term	Ayoxxa–Prosnav Capital: investment, 202203– financing round providing runway for 3-5 years incl new + lead investor Prosnav Capital NOT REALISED
	Person	Läufer, Albrecht (Ayoxxa 202203– CEO before Direvo + Corvay + BioRegioN Cluster Manager)
	Person 2	van Hall, André (BioCampus Cologne 201307– Prokurist before BioMedizinZentrum Dortmund)

Original document
accessed by [iito] on 2022-11-07

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Ayoxxa (Group)

[1] Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne....
[2] Ayoxxa Biosystems GmbH. (4/18/18). "Press Release: Ayoxxa Launches Lunaris Human 12-Plex Th17 Kit Expanding Its Portfolio for Fully Scalable Biomarker Analysis". Cologne....
[3] Ayoxxa Biosystems GmbH. (9/11/17). "Press Release: Ayoxxa Introduces Lunaris, Its Advanced Fully Integrated Low-volume Beads-on-a-Chip Multiplex Protein Analysis System". Cologne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]